Myriad Genetics Inc. (MYGN) News Headlines

▮ More

Date

Headline

3/30/2020 7:27:28 AM Myriad Files Application In Japan To Expand Indications For BRACAnalsyis

3/30/2020 7:19:38 AM Myriad Seeks Japanese Regulatory Approval For BRACAnalysis Diagnostic System

3/23/2020 7:08:29 AM Myriad Genetics Names Louise Phanstiel Chair Of Board

2/11/2020 7:07:33 AM Myriad Genetics Submits SPMA Application To FDA For Its MyChoice CDx Test

2/7/2020 10:58:33 AM Stock Alert: Myriad Genetics Stock Down 30%

2/6/2020 5:09:53 PM Myriad Genetics Q2 Results Miss Street, Outlook Weak; Shares Tank 29%

2/6/2020 4:51:20 PM Myriad Genetics Inc. Q2 adjusted earnings Miss Estimates

2/6/2020 4:08:07 PM Myriad Genetics Q2 Adjusted EPS $0.23 Vs $0.38 last Year

2/6/2020 3:02:41 PM Myriad Genetics Q2 20 Earnings Conference Call At 4:30 PM ET

1/22/2020 7:58:14 PM Myriad Submits SPMA For MyChoice CDx With Zejula In First-Line Platinum Responsive Advanced Ovarian Cancer

1/21/2020 7:09:59 AM Myriad Genetics Submits SPMA Application For Its BRACAnalysis CDx Test

1/14/2020 7:20:07 AM Myriad Genetics Names Thomas Slavin SVP Of Medical Affairs At Myriad Oncology

12/30/2019 7:07:34 AM Myriad Receives FDA Approval Of BRACAnalysis CDx As Companion Diagnostic For Lynparza

11/21/2019 7:37:58 AM Myriad Genetics Reports Regulatory Approval Of BRACAnalysis In Japan

11/21/2019 7:14:48 AM Myriad Genetics Says Japan's MHLW Approved BRACAnalysis Diagnostic System

11/4/2019 5:05:44 PM Myriad Genetics Lowers FY20 Financial Outlook; Shares Plunge

11/4/2019 4:11:00 PM Myriad Genetics Q1 Loss/share $0.28 Vs. Loss $0.01 Year Ago

10/21/2019 7:08:16 AM Myriad Genetics Names Mark Pollack Chief Medical Officer Of Myriad Neuroscience, Effective Jan. 15

9/16/2019 7:26:58 AM Myriad Genetics Enters Research Collaboration With University Of Leeds

8/22/2019 7:14:53 AM Myriad Genetics Applauds USPSTF Recommendation On BRCA-Related Cancer Prevention